abs378.txt	introduction		time-to-treatment-failure	(ttf)	is	the	interval	from	chemotherapyinitiation	to	premature	discontinuation	we	evaluated	ttf	based	on	age	methods	pooled	analyses	were	conducted	with	first-line	chemotherapy	trials	foradvanced	nsclc	(calgb	9730	30203	and	30801)	comparisons	among	patients	whowere	65	years	older	70	performed	for	(primaryendpoint)	reasons	early	cessation	grade	3+	adverse	events	andoverall	survival	results	1006	460	(46%)	than	of	onehundred	forty-five	(32%	this	cohort)	completed	all	sixplanned	cycles	as	did	170	(32%)	younger	median	was	2	9months	(95%	confidence	7-	3	2)	in	months	(95%confidence	9-3	5)	adjustment	performancestatus	stratification	by	trial	yielded	no	statisticallysignificant	age-based	difference	however	chemotherapycessation	differed	between	groups	(multivariate	p	=	0	004)	patientswere	less	likely	discontinue	cancer	progression	(41%	versus	55%)	morelikely	toxicity	or	patient	choice	(16%	15%	respectively)	compared	toyounger	(13%	6%	more	toexperience	(86%	79%)	an	cutpoint	70+	showed	nodifference	a	lower	trend	due	somewhat	shorter	conclusions	comparable	butdifferent	potentially	modifiable	account	it
